Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details)

v3.20.2
Organization and Nature of Operations (Details)
6 Months Ended
Jun. 30, 2020
Avalon Healthcare System, Inc. (“AHS”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation Delaware
Date of Incorporation May 18, 2015
Percentage of Ownership 100.00%
Principal Activities Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in United States of America ("USA")
Avalon (BVI) Ltd. (“Avalon BVI”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation British Virgin Island
Date of Incorporation Jan. 23, 2017
Percentage of Ownership 100.00%
Principal Activities Dormant, is in process of being dissolved
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation New Jersey
Date of Incorporation Feb. 07, 2017
Percentage of Ownership 100.00%
Principal Activities Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation PRC
Date of Incorporation Apr. 29, 2016
Percentage of Ownership 100.00%
Principal Activities Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in China
Genexosome Technologies Inc. (“Genexosome”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation Nevada
Date of Incorporation Jul. 31, 2017
Percentage of Ownership 60.00%
Principal Activities Develops proprietary diagnostic and therapeutic products using exosomes
Beijing Jieteng (Genexosome) Biotech Co., Ltd. ("Beijing Genexosome") [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation PRC
Date of Incorporation Aug. 07, 2015
Percentage of Ownership 100.00%
Principal Activities Provides development services for hospitals and other customers and sells developed items to hospitals and other customers in China
Avactis Biosciences Inc. (''Avactis'') [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation Nevada
Date of Incorporation Jul. 18, 2018
Percentage of Ownership 100.00%
Principal Activities Integrate and optimize global scientific and clinical resources to further advance cellular therapies, including regenerative medicine with stem/progenitor cells as well as cellular immunotherapy including CAR-T, CAR-NK, TCR-T and others to treat certain cancers
International Exosome Association LLC (''Exosome") [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation Delaware
Date of Incorporation Jun. 13, 2019
Percentage of Ownership 100.00%
Principal Activities Promotes standardization related to exosome industry